What are the serious risks associated with GLP-1 treatments (ie: Weight Loss injections) ?
Serious side effects from GLP-1 treatments such as Mounjaro and Wegovy are rare, but may include pancreatitis, gallbladder disease, and severe dehydration. Early recognition and prompt medical attention are essential.
Key Takeaways
- Serious complications are uncommon but clinically important
- Most risks can be managed safely with early detection
- You should seek urgent medical attention if severe symptoms occur
Detailed Explanation
GLP-1 receptor agonists affect gastrointestinal function and metabolic pathways. While generally well tolerated, there are rare but important risks to be aware of:
1. Pancreatitis (Inflammation of the pancreas)
This is a rare but serious condition.
Symptoms may include:
- Severe, persistent abdominal pain
- Pain that may radiate to the back
- Nausea and vomiting
Clinical relevance:
Pancreatitis requires immediate medical assessment and discontinuation of treatment.
2. Gallbladder Disease
GLP-1 treatments may increase the risk of gallstones or gallbladder inflammation.
Symptoms may include:
- Pain in the upper right abdomen
- Pain after eating fatty meals
- Nausea or vomiting
Clinical relevance:
Untreated gallbladder issues may require further investigation or surgical management.
3. Severe Dehydration
This may occur as a result of prolonged vomiting or diarrhoea.
Symptoms may include:
- Dizziness or weakness
- Reduced urination
- Dry mouth or increased thirst
Clinical relevance:
Dehydration can affect kidney function and may require medical treatment.
What You Should Do
- Stop taking your medication if you experience severe or concerning symptoms
- Seek urgent medical attention if symptoms suggest pancreatitis or severe illness
- Contact the Rightangled clinical team for further guidance
When to Seek Immediate Help
- Severe abdominal pain (especially if persistent)
- Repeated or uncontrollable vomiting
- Signs of dehydration or fainting